Meet Open Accelerator’s partners: Capital Cell

Today we are pleased to introduce our esteemed partner in this journey: Capital Cell. Together, we are dedicated to fostering innovation, driving positive change, and shaping the future of life sciences.  

Capital Cell leads the charge in revolutionizing investment, focusing solely on the dynamic fields of Health and Biotechnology. Since its inception in 2015, the platform has carefully curated a lineup of promising ventures, all meticulously vetted by a team of experts and esteemed partners like Alira Health. 

Capital Cell is committed to making investing accessible to everyone. Whether you're a big spender or working with a tight budget, investors can jump in with investments starting as low as €100. The platform's track record speaks volumes: out of 2600 projects reviewed, Capital Cell has facilitated 104 successful fundraises and maintained an impressive 93% survival rate for its portfolio. Additionally, 40% of investment rounds are conducted in collaboration with venture capitalists, magnifying the impact of each investment. 

The platform prioritizes regulatory compliance. Fully licensed under the oversight of the Spanish stock market authority, the Comisión Nacional del Mercado de Valores (CNMV), Capital Cell obtained its ECSP license in 2023. Regular audits ensure transparency and investor confidence. 

Central to Capital Cell's success is its network of over 3400 vetted experts who inform investment decisions. The BioExpert Network, endorsing about half of the projects it reviews, serves as Capital Cell's primary resource for scalable startup analysis, ensuring only the best ventures are showcased. 

Ultimately, Capital Cell is more than just an investment platform—it's a catalyst for change in health and biotech, offering everyone the opportunity to shape the future. Investors can join Capital Cell and be part of something bigger. Invest in the future. Invest in life sciences. 

During April to September 2023, Capital Cell expanded its operations across Europe. It formed partnerships with LEH in Holland, negotiated deals with Noshaq VC and the Wallon Regional fund in Belgium, and engaged in advanced discussions with the Zambon Group and HTH in Italy. At the EU level, Capital Cell collaborated with Alira Health, partnered with EIT Health, and secured recognition as investors for EIC funding. These endeavors underscore Capital Cell's commitment to fostering innovation and driving positive change on a broader scale. 

A big thank you to Capital Cell for their partnership with Open Accelerator.    

Discover More about CapitalCell here: Capital Cell | Invierte con especialistas en Biotecnología